InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

- Current share price for 4DX : $2.160

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$1,301 Initial Director's Interest Notice 20 Nov 2026 4:50PM $2.160 $2.160 fallen by 0%
$1,301 Cleansing Notice 20 Nov 2026 4:41PM $2.160 $2.160 fallen by 0%
$1,301 Application for quotation of securities - 4DX 20 Nov 2026 4:34PM $2.160 $2.160 fallen by 0%
$1,301 Former ResMed CFO Brett Sandercock joins 4DMedical Board 16 Nov 2026 9:52AM $2.300 $2.160 fallen by 6.09%
$1,301 Application for quotation of securities - 4DX 13 Nov 2026 4:31PM $2.300 $2.160 fallen by 6.09%
$1,301 Becoming a substantial holder 5 Nov 2026 8:20AM $2.150 $2.160 risen by 0.47%
$1,301 Response to ASX Price Query 2 Nov 2026 10:29AM $2.440 $2.160 fallen by 11.48%
$1,301 Pause in Trading 2 Nov 2026 9:50AM $2.440 $2.160 fallen by 11.48%
$1,301 Application for quotation of securities - 4DX 30 Oct 2026 4:21PM $2.440 $2.160 fallen by 11.48%
$1,301 Final Director's Interest Notice -LB 30 Oct 2026 4:20PM $2.440 $2.160 fallen by 11.48%
$1,301 Results of AGM 28 Oct 2026 2:37PM $3.520 $2.160 fallen by 38.64%
$1,301 Quarterly Activity Report and Appendix 4C 28 Oct 2026 9:31AM $3.610 $2.160 fallen by 40.17%
$1,301 AGM Presentation and Chair's address 28 Oct 2026 9:07AM $3.610 $2.160 fallen by 40.17%
$1,301 Notice of 2026 Annual General Meeting - Clarification 23 Oct 2026 5:34PM $3.670 $2.160 fallen by 41.14%
$1,301 Application for quotation of securities - 4DX 16 Oct 2026 4:31PM $4.090 $2.160 fallen by 47.19%
$1,301 Addendum to 2026 Notice of Annual General Meeting 16 Oct 2026 9:30AM $4.080 $2.160 fallen by 47.06%
$1,301 Notification of cessation of securities - 4DX 2 Oct 2026 4:22PM $4.340 $2.160 fallen by 50.23%
$1,301 Application for quotation of securities - 4DX 2 Oct 2026 4:20PM $4.340 $2.160 fallen by 50.23%
$1,301 Ceasing to be a substantial holder 28 Sep 2026 8:16AM $4.000 $2.160 fallen by 46%
$1,301 Becoming a substantial holder 25 Sep 2026 8:12AM $4.100 $2.160 fallen by 47.32%
$1,301 Notice of Annual General Meeting/Proxy Form 24 Sep 2026 9:37AM $4.080 $2.160 fallen by 47.06%
$1,301 Appendix 4G and Corporate Governance Statement 24 Sep 2026 9:28AM $4.080 $2.160 fallen by 47.06%
$1,301 FY26 Annual Report 24 Sep 2026 9:19AM $4.080 $2.160 fallen by 47.06%
$1,301 Initial Director's Interest Notice - CJ 23 Sep 2026 6:53PM $4.080 $2.160 fallen by 47.06%
$1,301 Board transition and key personnel appointments 23 Sep 2026 6:50PM $4.080 $2.160 fallen by 47.06%

1 - 25 of 623 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.